Abstract:We have previously demonstrated that human peripheral blood low density mononuclear cells cultured in granulocyte/macrophage colony-stimulating factor (GM-CSF) and interleukin (IL)-4 develop into dendritic cells (DCs) that are extremely efficient in presenting soluble antigens to T cells. To identify the mechanisms responsible for efficient antigen capture, we studied the endocytic capacity of DCs using fluorescein isothiocyanate-dextran, horseradish peroxidase, and lucifer yellow. We found that DCs use two distinct mechanisms for antigen capture. The first is a high level of fluid phase uptake via macropinocytosis. In contrast to what has been found with other cell types, macropinocytosis in DCs is constitutive and allows continuous internalization of large volumes of fluid. The second mechanism of capture is mediated via the mannose receptor (MR), which is expressed at high levels on DCs. At low ligand concentrations, the MR can deliver a large number of ligands to the cell in successive rounds. Thus, while macropinocytosis endows DCs with a high capacity, nonsaturable mechanism for capture of any soluble antigen, the MR gives an extra capacity for antigen capture with some degree of selectivity for non-self molecules. In addition to their high endocytic capacity, DCs from GM-CSF + IL-4-dependent cultures are characterized by the presence of a large intracellular compartment that contains high levels of class II molecules, cathepsin D, and lysosomal- associated membrane protein-1, and is rapidly accessible to endocytic markers. We investigated whether the capacity of DCs to capture and process antigen could be modulated by exogenous stimuli. We found that DCs respond to tumor necrosis factor alpha, CD40 ligand, IL-1, and lipopolysaccharide with a coordinate series of changes that include downregulation of macropinocytosis and Fc receptors, disappearance of the class II compartment, and upregulation of adhesion and costimulatory molecules. These changes occur within 1-2 d and are irreversible, since neither pinocytosis nor the class II compartment are recovered when the maturation-inducing stimulus is removed. The specificity of the MR and the capacity to respond to inflammatory stimuli maximize the capacity of DCs to present infectious non-self antigens to T cells.

Effect of growth hormone replacement on bone mass in adults with adult onset growth hormone deficiency

Cis Interactions Between CD2 and Its Ligands on T Cells Are Required for T Cell Activation

Integrin CD11b Negatively Regulates TLR9-triggered Dendritic Cell Cross-Priming by Upregulating Microrna-146A.

Transcriptional control of dendritic cell development and functions

Ectasia of the basilar artery: The breadth of the clinical spectrum and the diagnostic value of computed tomography

The “Boomerang” Malleus-Incus Complex in Congenital Aural Atresia

Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation

Antigen presentation by dendritic cells and their instruction of CD4+ T helper cell responses

TLR9-dependent dendritic cell maturation promotes IL-6-mediated upregulation of cathepsin X

Transcriptional regulation of dendritic cell development and function

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

tRNA-m 1 A modification promotes T cell expansion via efficient MYC protein synthesis

Transcriptional reprogramming via signaling domains of CD2, CD28 and 4-1BB

Induction and transcriptional regulation of the co-inhibitory gene module in T cells

Differentially Tolerized Mouse Antigen Presenting Cells Share a Common miRNA Signature Including Enhanced mmu-miR-223-3p Expression Which Is Sufficient to Imprint a Protolerogenic State

Differential activation profiles of multiple transcription factors during dendritic cell maturation.

XPC: its product and biological roles.

The Transcription Factors PU.1 and IRF4 Determine Dendritic Cell–Specific Expression of RALDH2

Pain and dementia

Tropomodulin1 Expression Increases Upon Maturation in Dendritic Cells and Promotes Their Maturation and Immune Functions

Control of T Helper 2 Responses by Transcription Factor Irf4-Dependent Dendritic Cells